Healthcare provider profile · identity verified

John A Woodruff, M.D.

Internal Medicine · OMAHA, NE · NPI 1700809464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	624	154
Amlodipine Besylate	Amlodipine Besylate	482	117
Levothyroxine Sodium	Levothyroxine Sodium	359	78
Losartan Potassium	Losartan Potassium	322	81
Gabapentin	Gabapentin	321	64
Omeprazole	Omeprazole	276	72
Metoprolol Succinate	Metoprolol Succinate	274	53
Hydrochlorothiazide	Hydrochlorothiazide	186	44
Simvastatin	Simvastatin	170	43
Pravastatin Sodium	Pravastatin Sodium	168	38
Pantoprazole Sodium	Pantoprazole Sodium	156	30
Duloxetine Hcl	Duloxetine Hcl	146	19
Lisinopril	Lisinopril	146	37
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	135	37
Furosemide	Furosemide	130	29
Atenolol	Atenolol	128	29
Tamsulosin Hcl	Tamsulosin Hcl	127	31
Escitalopram Oxalate	Escitalopram Oxalate	124	23
Allopurinol	Allopurinol	122	26
Alendronate Sodium	Alendronate Sodium	120	28
Metformin Hcl Er	Metformin Hcl	114	33
Rosuvastatin Calcium	Rosuvastatin Calcium	101	32
Tramadol Hcl	Tramadol Hcl	96	26
Spironolactone	Spironolactone	95	25
Potassium Chloride	Potassium Chloride	92	20
Eliquis	Apixaban	91	14
Clopidogrel	Clopidogrel Bisulfate	84	21
Prednisone	Prednisone	80	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	16
Sertraline Hcl	Sertraline Hcl	77	16
Metoprolol Tartrate	Metoprolol Tartrate	74	18
Xarelto	Rivaroxaban	65	suppressed
Carvedilol	Carvedilol	63	suppressed
Mirtazapine	Mirtazapine	63	12
Trazodone Hcl	Trazodone Hcl	63	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	26
Meloxicam	Meloxicam	61	16
Alprazolam	Alprazolam	56	16
Fluticasone Propionate	Fluticasone Propionate	56	17
Glimepiride	Glimepiride	54	13
Mounjaro	Tirzepatide	54	suppressed
Metformin Hcl	Metformin Hcl	53	12
Fluoxetine Hcl	Fluoxetine Hcl	50	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	49	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	43	11
Celecoxib	Celecoxib	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	37	11
Warfarin Sodium	Warfarin Sodium	37	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	21
Oxycodone Hcl	Oxycodone Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Jardiance	Empagliflozin	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Lorazepam	Lorazepam	29	12
Bupropion Xl	Bupropion Hcl	28	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Cephalexin	Cephalexin	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Ozempic	Semaglutide	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	18
Benazepril Hcl	Benazepril Hcl	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Ramipril	Ramipril	22	suppressed
Amoxicillin	Amoxicillin	21	14
Farxiga	Dapagliflozin Propanediol	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Naproxen	Naproxen	20	suppressed
Methadone Hcl	Methadone Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Torsemide	Torsemide	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	15
Finasteride	Finasteride	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Primidone	Primidone	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Topiramate	Topiramate	14	suppressed
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Testosterone	Testosterone	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error